Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Obesity-related conditions

Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease

W. P. Martin; Y. H. D. Chuah; M. Abdelaal; A. Pedersen; D. Malmodin; S. Abrahamsson; M. Hutter; C. Godson; E. P. Brennan; L. Fändriks; C. W. le Roux; N. G. Docherty Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease Front Endocrinol (Lausanne)
Chronic Kidney Disease Insulin Resistance & Diabetes

Remission of hidradenitis suppurativa after bariatric surgery

C. Gallagher; S. Kirthi; T. Burke; D. O'Shea; A. M. Tobin Remission of hidradenitis suppurativa after bariatric surgery JAAD Case Rep

Effect of Bariatric Surgery on CKD Risk

A. N. Friedman; A. S. Wahed; J. Wang; A. P. Courcoulas; G. Dakin; M. W. Hinojosa; P. L. Kimmel; J. E. Mitchell; A. Pomp; W. J. Pories; J. Q. Purnell; C. le Roux; K. Spaniolas; K. J. Steffen; R. Thirlby; B. Wolfe Effect of Bariatric Surgery on CKD Risk J Am Soc Nephrol
Chronic Kidney Disease

The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes

A. N. Friedman; J. Wang; A. S. Wahed; N. G. Docherty; E. Fennern; A. Pomp; J. Q. Purnell; C. W. le Roux; B. Wolfe The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes Am J Kidney Dis
Chronic Kidney Disease Insulin Resistance & Diabetes

The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials

N. M. Fearon; E. C. Kearns; C. A. Kennedy; J. B. Conneely; H. M. Heneghan The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials Surg Obes Relat Dis

Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation

E. Donnellan; O. M. Wazni; M. Kanj; B. Baranowski; P. Cremer; S. Harb; C. P. McCarthy; J. W. McEvoy; M. B. Elshazly; P. Aagaard; K. G. Tarakji; W. A. Jaber; P. R. Schauer; W. I. Saliba Association between pre-ablation bariatric surgery and atrial fibrillation recurrence in morbidly obese patients undergoing atrial fibrillation ablation Europace

Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease

N. G. Docherty; C. W. le Roux Improvements in the metabolic milieu following Roux-en-Y gastric bypass and the arrest of diabetic kidney disease Exp Physiol
Chronic Kidney Disease Metabolic Syndrome

Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus

N. G. Docherty; C. W. le Roux Bariatric surgery for the treatment of chronic kidney disease in obesity and type 2 diabetes mellitus Nature reviews nephrology
Chronic Kidney Disease Insulin Resistance & Diabetes

The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes-Reply

R. V. Cohen; T. V. Pereira; C. W. le Roux The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes-Reply JAMA Surg
Chronic Kidney Disease Insulin Resistance & Diabetes

Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial

R. V. Cohen; T. B. Z. Petry; A. D. Miras; C. M. Aboud; B. Johnson; T. M. Dos Santos; C. W. le Roux Renoprotective Effects of the Combination of Empagliflozin and Liraglutide Compared With Roux-en-Y Gastric Bypass in Early-Stage Diabetic Kidney Disease: A Post Hoc Analysis of the Microvascular Outcomes after Metabolic Surgery (MOMS) Randomized Controlled Clinical Trial Diabetes Care
Chronic Kidney Disease

Older posts

Newer posts

← Previous Page1 … Page17 Page18 Page19 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Menu

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2024 ASOI